Etamicastat, also known as BIA 5-453, is a potent, reversible, peripherally selective dopamine -hydroxylase inhibitor (DBH inhibitor). Chronic dopamine ß-hydroxylase inhibition with etamicastat effectively decreases blood pressure, although does not prevent the development of hypertension in the spontaneously hypertensive rat.
For research use only. We do not sell to patients.